179 related articles for article (PubMed ID: 12006423)
1. Reduced interleukin-18 levels in BAL specimens from patients with asthma compared to patients with sarcoidosis and healthy control subjects.
Ho LP; Davis M; Denison A; Wood FT; Greening AP
Chest; 2002 May; 121(5):1421-6. PubMed ID: 12006423
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis.
Girgis RE; Basha MA; Maliarik M; Popovich J; Iannuzzi MC
Am J Respir Crit Care Med; 1995 Jul; 152(1):71-5. PubMed ID: 7599865
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of interleukin-18 in patients with pulmonary sarcoidosis.
Shigehara K; Shijubo N; Ohmichi M; Yamada G; Takahashi R; Okamura H; Kurimoto M; Hiraga Y; Tatsuno T; Abe S; Sato N
Am J Respir Crit Care Med; 2000 Nov; 162(5):1979-82. PubMed ID: 11069843
[TBL] [Abstract][Full Text] [Related]
4. Increased interleukin-13 expression in patients with sarcoidosis.
Hauber HP; Gholami D; Meyer A; Pforte A
Thorax; 2003 Jun; 58(6):519-24. PubMed ID: 12775866
[TBL] [Abstract][Full Text] [Related]
5. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
[TBL] [Abstract][Full Text] [Related]
6. Inter-relationship between tumour necrosis factor-alpha (TNF-alpha) and TNF soluble receptors in pulmonary sarcoidosis.
Armstrong L; Foley NM; Millar AB
Thorax; 1999 Jun; 54(6):524-30. PubMed ID: 10335007
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-18 expression in BAL cells of sarcoidosis patients is decreased in vivo but protein secretion is not impaired in vitro.
Hauber HP; Beyer IS; Meyer A; Pforte A
Respir Med; 2003 May; 97(5):521-7. PubMed ID: 12735669
[TBL] [Abstract][Full Text] [Related]
8. Reduced production of interleukin 12 by interferon gamma primed alveolar macrophages from atopic asthmatic subjects.
Plummeridge MJ; Armstrong L; Birchall MA; Millar AB
Thorax; 2000 Oct; 55(10):842-7. PubMed ID: 10992536
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
Mroz RM; Korniluk M; Stasiak-Barmuta A; Chyczewska E
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():507-13. PubMed ID: 19218675
[TBL] [Abstract][Full Text] [Related]
10. Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics.
Folkard SG; Westwick J; Millar AB
Eur Respir J; 1997 Sep; 10(9):2097-104. PubMed ID: 9311510
[TBL] [Abstract][Full Text] [Related]
11. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs.
Shigehara K; Shijubo N; Ohmichi M; Takahashi R; Kon S; Okamura H; Kurimoto M; Hiraga Y; Tatsuno T; Abe S; Sato N
J Immunol; 2001 Jan; 166(1):642-9. PubMed ID: 11123348
[TBL] [Abstract][Full Text] [Related]
12. Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis.
Terao I; Hashimoto S; Horie T
Int Arch Allergy Immunol; 1993; 102(3):242-8. PubMed ID: 8219777
[TBL] [Abstract][Full Text] [Related]
13. IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy.
Tang C; Rolland JM; Ward C; Quan B; Walters EH
Eur Respir J; 1997 Mar; 10(3):624-32. PubMed ID: 9072996
[TBL] [Abstract][Full Text] [Related]
14. [Activation of CD4+ T cells and increased release of interleukin-5 in cultures of bronchoalveolar lavage cells and PBMC from patients with asthma].
Tang C; Quan B; Wang D
Zhonghua Nei Ke Za Zhi; 1996 Apr; 35(4):223-7. PubMed ID: 9387634
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor CXCR3 ligands in bronchoalveolar lavage fluid: associations with radiological pattern, clinical course, and prognosis in sarcoidosis.
Piotrowski WJ; Młynarski W; Fendler W; Wyka K; Marczak J; Górski P; Antczak A
Pol Arch Med Wewn; 2014; 124(7-8):395-402. PubMed ID: 24859629
[TBL] [Abstract][Full Text] [Related]
16. Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis.
Zheng L; Teschler H; Guzman J; Hübner K; Striz I; Costabel U
Am J Respir Crit Care Med; 1995 Sep; 152(3):1061-6. PubMed ID: 7663784
[TBL] [Abstract][Full Text] [Related]
17. Significance of the interleukin-1 receptor antagonist/interleukin-1 beta ratio as a prognostic factor in patients with pulmonary sarcoidosis.
Mikuniya T; Nagai S; Takeuchi M; Mio T; Hoshino Y; Miki H; Shigematsu M; Hamada K; Izumi T
Respiration; 2000; 67(4):389-96. PubMed ID: 10940792
[TBL] [Abstract][Full Text] [Related]
18. The value of interleukin-12 as an activity marker of pulmonary sarcoidosis.
Kim DS; Jeon YG; Shim TS; Lim CM; Lee SD; Koh Y; Kim WS; Kim WD
Sarcoidosis Vasc Diffuse Lung Dis; 2000 Oct; 17(3):271-6. PubMed ID: 11033843
[TBL] [Abstract][Full Text] [Related]
19. Exposure to systemic prednisolone for 4 hours reduces ex vivo synthesis of GM-CSF by bronchoalveolar lavage cells and blood mononuclear cells of mild allergic asthmatics.
Cotter TP; Hood PP; Costello JF; Sampson AP
Clin Exp Allergy; 1999 Dec; 29(12):1655-62. PubMed ID: 10594542
[TBL] [Abstract][Full Text] [Related]
20. No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.
Wikén M; Idali F; Al Hayja MA; Grunewald J; Eklund A; Wahlström J
Respir Res; 2010 Sep; 11(1):121. PubMed ID: 20813038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]